Feldmann Marc 4
4 · 180 Life Sciences Corp. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
Feldmann Marc
Director10% Owner
Transactions
- Sale
Common Stock
2023-12-15$0.19/sh−25,000$4,700→ 115,497 total
Footnotes (1)
- [F1]Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.